Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$4.62−0.21 (-4.35%)
Close on Nov 17, 2026Market cap $522.33MP/E –Yield –
Evolent Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Evolent Health's operating cash flow for the twelve months ending Jun 30, 2026 was $54.32M. For fiscal 2025 it was $38.84M, up 107.0% from the year before. The highest annual figure on record is $142.58M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.84M | +107.0% |
| FY2024 | Dec 31, 2024 | $18.77M | -86.8% |
| FY2023 | Dec 31, 2023 | $142.58M | – |
| FY2022 | Dec 31, 2022 | -$11.55M | -129.8% |
| FY2021 | Dec 31, 2021 | $38.75M | – |
| FY2020 | Dec 31, 2020 | -$16.23M | – |
| FY2019 | Dec 31, 2019 | -$42.65M | – |
| FY2018 | Dec 31, 2018 | -$20.65M | – |
| FY2017 | Dec 31, 2017 | -$27.96M | – |
| FY2016 | Dec 31, 2016 | -$35.51M | – |
| FY2015 | Dec 31, 2015 | -$18.47M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | -$13.63M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$984.00K | -121.6% |
| Q4 FY2025 | Dec 31, 2025 | $48.80M | – |
| Q3 FY2025 | Sep 30, 2025 | $15.81M | -15.3% |
| Q2 FY2025 | Jun 30, 2025 | -$30.33M | -241.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.57M | -7.0% |
| Q4 FY2024 | Dec 31, 2024 | -$26.23M | -129.3% |
| Q3 FY2024 | Sep 30, 2024 | $18.67M | -69.2% |
| Q2 FY2024 | Jun 30, 2024 | $21.42M | +3174.8% |
| Q1 FY2024 | Mar 31, 2024 | $4.91M | – |
| Q4 FY2023 | Dec 31, 2023 | $89.38M | +150.4% |
| Q3 FY2023 | Sep 30, 2023 | $60.52M | – |
| Q2 FY2023 | Jun 30, 2023 | $654.00K | -95.2% |
| Q1 FY2023 | Mar 31, 2023 | -$7.97M | – |
| Q4 FY2022 | Dec 31, 2022 | $35.70M | -46.4% |
| Q3 FY2022 | Sep 30, 2022 | -$3.47M | -107.8% |
| Q2 FY2022 | Jun 30, 2022 | $13.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.44M | – |
| Q4 FY2021 | Dec 31, 2021 | $66.66M | – |
| Q3 FY2021 | Sep 30, 2021 | $44.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$24.25M | -164.4% |
| Q1 FY2021 | Mar 31, 2021 | -$48.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.85M | -197.5% |
| Q3 FY2020 | Sep 30, 2020 | -$20.50M | – |
| Q2 FY2020 | Jun 30, 2020 | $37.67M | – |
| Q1 FY2020 | Mar 31, 2020 | -$20.54M | – |
| Q4 FY2019 | Dec 31, 2019 | $13.19M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.59M | -174.3% |
| Q2 FY2019 | Jun 30, 2019 | -$13.53M | -302.0% |
| Q1 FY2019 | Mar 31, 2019 | -$25.71M | – |
| Q4 FY2018 | Dec 31, 2018 | -$24.97M | -513.7% |
| Q3 FY2018 | Sep 30, 2018 | $22.32M | +484.5% |
| Q2 FY2018 | Jun 30, 2018 | $6.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$24.71M | – |
| Q4 FY2017 | Dec 31, 2017 | $6.04M | – |
| Q3 FY2017 | Sep 30, 2017 | $3.82M | -51.7% |
| Q2 FY2017 | Jun 30, 2017 | -$3.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$34.77M | – |
| Q4 FY2016 | Dec 31, 2016 | -$21.51M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.91M | – |
See a number that looks wrong?